Salesforce Hits $45B ARR, cRPO Jumps 14% and Anthropic Stake Fuels EPS Surge
Salesforce announced it has crossed the $45 billion ARR threshold, with contracted‑but‑unrecognized revenue (cRPO) up 14% YoY and earnings per share lifted to $2.53 by gains on its Anthropic investment. The results underscore a re‑acceleration in bookings, modest organic growth after stripping Informatica, and a capital‑allocation play that combined a $25 billion buyback with a rising AI‑focused portfolio.
Why It Matters
Salesforce’s crossing of the $45 billion ARR threshold validates the scalability of its platform and signals that large‑scale SaaS firms can still generate meaningful growth through a mix of new bookings, strategic AI investments, and disciplined capital returns. The 14% cRPO acceleration suggests a healthier pipeline that could translate into double‑digit revenue growth in the second half of FY27, a critical metric for investors watching the post‑pandemic SaaS recovery.
The Anthropic stake illustrates a growing trend of SaaS operators treating AI as a balance‑sheet asset rather than a pure expense, potentially reshaping valuation models that traditionally discount AI spend. Meanwhile, the heavy buyback and rising debt highlight a capital‑allocation dilemma: whether to prioritize shareholder returns or reinvest in AI‑driven product innovation. How Salesforce balances these levers will influence competitive dynamics with AI‑first rivals like Snowflake and Microsoft’s Dynamics suite.
Key Points
- Salesforce reached $45 B ARR in Q2 FY27
- cRPO grew 14% YoY to $33.5 B, indicating strong recent bookings
- Organic revenue (ex‑Informatica) rose 6.4% to $10.889 B
- EPS jumped 103% to $2.53, driven by Anthropic stake gains and a $25 B buyback
- AI‑and‑data ARR now $3.9 B, roughly 8% of total revenue
Analysis
Salesforce’s latest results underscore a strategic pivot toward AI‑centric growth while still leveraging its massive enterprise install base. The 14% cRPO surge is more than a bookkeeping footnote; it reflects a pipeline that is outpacing the lagging revenue curve, a rare occurrence for a company of this size. If Salesforce can convert that pipeline into recognized revenue, it could sustain double‑digit top‑line growth despite macro‑economic headwinds that have slowed many peers.
The Anthropic investment is a textbook case of a SaaS firm using its cash reserves to acquire a quasi‑strategic equity position that both hedges against AI disruption and creates a new earnings lever. By treating the AI stake as a quasi‑operating asset, Salesforce sidesteps the typical R&D expense model and offers investors a clearer path to profitability. However, the accompanying debt increase raises questions about balance‑sheet resilience, especially if AI adoption timelines slip.
Finally, the modest organic growth after stripping Informatica signals that Salesforce’s core subscription engine is stabilizing rather than accelerating. The company’s ability to cross‑sell AI and data platforms will be the next frontier. Competitors that can bundle AI more tightly with core CRM functions may erode Salesforce’s moat, making the upcoming H2 performance a litmus test for the effectiveness of its AI‑first strategy.